Nestle Buys Phagenesis

Nestle Health Science backs medical device company developing product to help consumers swallow food.

Nestle / Photo: nbcnews.com
Nestle / Photo: nbcnews.com

A September 1st Reuters article announced Nestle Health Science will buy British medical device company Phagenesis in phases. The deal will consist of an undisclosed upfront payment followed by milestone-based funding related to Phagenyx, a device that employs electrical stimulation to help sufferers of dysphagia, a condition that usually affects stroke survivors’ ability to swallow.

The deal is the latest in Swiss-based Nestle’s acquisition schedule in the area of medicine that marries food and pharmaceuticals. "It could be the start of many more to come," said Jon Cox, an analyst at Kepler Cheuvreux. "Nestle has made a clear statement of intent with the appointment of Ulf Mark Schneider to become CEO that it will develop its health and nutrition business."

Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report